XML 18 R7.htm IDEA: XBRL DOCUMENT v3.8.0.1
Condensed Consolidated Statements of Cash Flows - USD ($)
9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net income $ 188,088,000 $ 42,218,000
Adjustments to reconcile net income to net cash provided by operating activities:    
Gain on sale of investment properties (119,729,000) (13,944,000)
Depreciation and amortization, including discontinued operations 152,546,000 96,192,000
Amortization of deferred financing costs and premium/discount on notes payable (2,543,000) 1,063,000
Stock-based compensation expense, net of forfeitures 2,486,000 1,571,000
Effect of certain non-cash adjustments to rental revenues (33,379,000) (15,966,000)
Income from unconsolidated joint ventures (43,362,000) (5,144,000)
Operating distributions from unconsolidated joint ventures 40,207,000 5,893,000
Gain on extinguishment of debt (2,258,000) 0
Changes in other operating assets and liabilities:    
Change in other receivables and other assets, net 9,707,000 1,824,000
Change in operating liabilities 3,150,000 5,544,000
Net cash provided by operating activities 194,913,000 119,251,000
CASH FLOWS FROM INVESTING ACTIVITIES:    
Proceeds from investment property sales 171,316,000 21,088,000
Property acquisition, development, and tenant asset expenditures (229,811,000) (122,357,000)
Purchase of tenant in common interest (13,382,000) 0
Collection of notes receivable 5,161,000 0
Investment in unconsolidated joint ventures (13,862,000) (24,918,000)
Distributions from unconsolidated joint ventures 40,939,000 4,150,000
Change in notes receivable and other assets (1,348,000) (5,699,000)
Change in restricted cash 15,105,000 (3,667,000)
Net cash used in investing activities (25,882,000) (131,403,000)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from credit facility 589,300,000 182,800,000
Repayment of credit facility (723,300,000) (274,800,000)
Proceeds from issuance of notes payable 350,000,000 270,000,000
Repayment of notes payable (493,774,000) (7,239,000)
Payment of deferred financing costs (2,048,000) (1,604,000)
Shares withheld for payment of taxes on restricted stock vesting (701,000) 0
Common stock issued, net of expenses 211,598,000 0
Contributions from noncontrolling interests 1,588,000 2,525,000
Distributions to nonredeemable noncontrolling interests (1,364,000) 0
Repurchase of common stock 0 (13,743,000)
Common dividends paid (73,950,000) (50,549,000)
Other 100,000 0
Net cash provided by (used in) financing activities (142,551,000) 107,390,000
NET INCREASE IN CASH AND CASH EQUIVALENTS 26,480,000 95,238,000
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD 35,687,000 2,003,000
CASH AND CASH EQUIVALENTS AT END OF PERIOD 62,167,000 97,241,000
Interest paid, net of amounts capitalized 26,927,000 20,792,000
Significant non-cash transactions:    
Transfer from operating properties to real estate assets and other assets held for sale 0 203,735,000
Transfer from operating properties to liabilities of real estate assets held for sale 0 106,135,000
Transfer from investment in unconsolidated joint ventures to operating properties 68,390,000 0
Transfer from projects under development to operating properties 58,928,000 0
Common stock dividends declared 25,201,000 0
Transfer from investment in unconsolidated joint ventures to projects under development 0 5,880,000
Transfer from land held to projects under development 0 8,099,000
Change in accrued property acquisition, development, and tenant asset expenditures $ (18,081,000) $ (11,384,000)